Butterfly Network
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domes...
Latest News
3 days ago · marketbeat.com
Butterfly Network CEO Sees Chip Revenue Dwarfing Ultrasound Device BusinessButterfly Network NYSE: BFLY is expanding beyond its handheld point-of-care ultrasound business by licensing its semiconductor technology to other companies, CEO Joe DeVivo said during a discussion with UBS MedTech team member Patrick Wood.
6 days ago · seekingalpha.com
Butterfly Network, Inc. (BFLY) Presents at 2026 UBS Global Healthcare Conference TranscriptButterfly Network, Inc. (BFLY) Presents at 2026 UBS Global Healthcare Conference Transcript
18 days ago · marketbeat.com
Butterfly Network Q3 Earnings Call HighlightsButterfly Network NYSE: BFLY reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused point-of-care ultrasound operations lifted results.
18 days ago · seekingalpha.com
Butterfly Network, Inc. (BFLY) Q3 2026 Earnings Call TranscriptButterfly Network, Inc. ( BFLY ) Q3 2026 Earnings Call October 29, 2026 8:00 AM EDT Company Participants John Doherty - Executive VP & CFO Joseph DeVivo - CEO, President & Chairman of the Board Conference Call Participants Joshua Jennings - TD Cowen, Research Division William Plovanic - Canaccord Genuity Corp., Research Division David Saxon - Needham & Company, LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Steven Lichtman - William Blair & Company L.L.C., Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ilya Zubkov - Freedom Broker, Research Division Presentation Operator Hello, everyone.
19 days ago · zacks.com
Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Beats Revenue EstimatesButterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.13 per share a year ago.
1 month ago · businesswire.com
The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound EducationBURLINGTON, Mass. & BLACKSBURG, Va.--(BUSINESS WIRE)---- $BFLY #POCUS--The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network, Inc. (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced a long-term alliance and joint investment in establishing VCOM and its students as a center of excellence for ultrasound education and community care. The first-of-its-kind program combines one-probe-per-student deployment, integrated education a.
1 month ago · investorplace.com
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain RaceElon Musk's Neuralink is giving us a glimpse of a future in which the human brain can communicate directly with computers. For investors, there's just one problem: You can't buy Neuralink stock.
1 month ago · businesswire.com
Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcas.
1 month ago · benzinga.com
Butterfly Network Lands Multi-Year Bridge Neurotech DealButterfly Network Inc. (NYSE:BFLY) is partnering with Bridge Neurotech to develop a fully non-invasive brain-computer interface using ultrasound technology.
2 months ago · businesswire.com
Mendaera's Focalist™ System Now Compatible with Butterfly's Ultrasound-on-Chip™ TechnologyBURLINGTON, Mass. & SAN MATEO, Calif.--(BUSINESS WIRE)---- $BFLY #POCUS--Mendaera, Inc., a healthcare technology company building robotics and intelligence for procedural medicine, and Butterfly Network, Inc. (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced that Mendaera's Focalist™ system is now commercially available with Butterfly Network's Ultrasound-on-Chip™ imaging technology. Mendaera's FDA-cleared Focalist system combines handheld.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove BFLY